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Abstract
Objectives This study aimed at developing technical recommendations for the acquisition, processing and analysis of renal 
ASL data in the human kidney at 1.5 T and 3 T field strengths that can promote standardization of renal perfusion measure-
ments and facilitate the comparability of results across scanners and in multi-centre clinical studies.
Methods An international panel of 23 renal ASL experts followed a modified Delphi process, including on-line surveys and 
two in-person meetings, to formulate a series of consensus statements regarding patient preparation, hardware, acquisition 
protocol, analysis steps and data reporting.
Results Fifty-nine statements achieved consensus, while agreement could not be reached on two statements related to 
patient preparation. As a default protocol, the panel recommends pseudo-continuous (PCASL) or flow-sensitive alternating 
inversion recovery (FAIR) labelling with a single-slice spin-echo EPI readout with background suppression and a simple 
but robust quantification model.
Discussion This approach is considered robust and reproducible and can provide renal perfusion images of adequate quality 
and SNR for most applications. If extended kidney coverage is desirable, a 2D multislice readout is recommended. These 
recommendations are based on current available evidence and expert opinion. Nonetheless they are expected to be updated 
as more data become available, since the renal ASL literature is rapidly expanding.
Keywords MRI · Arterial spin labelling · Kidney · Perfusion · Renal blood flow
Introduction
Blood delivery to the tissue capillary bed (i.e. tissue perfu-
sion) is critical to enable normal function, maintenance, and 
survival of physiological systems. In particular, the kidneys 
rely on a major, tightly regulated and continual supply of 
blood not only to remain viable but also to perform their key 
role in homeostasis, with filtration at the level of individual 
glomeruli at the forefront. Disruption of renal perfusion 
is linked to an array of pathophysiological mechanisms in 
acute kidney injury (AKI) as well as chronic kidney disease 
(CKD), with renal hypoperfusion (and subsequent hypoxia 
and fibrosis) involved in the former and potentially promot-
ing progression of the latter [1–3]. As such, methods to 
accurately measure and monitor changes in renal perfusion 
would be of immense benefit to the clinic as well as allow 
novel investigations of renal function in vivo, particularly 
if able to do so at early stages of disease and in a safe and 
non-invasive way.
Arterial spin labelling (ASL), a magnetic resonance 
imaging (MRI) technique proposed over 25 years ago [4, 
5], has arisen as one of the prime candidates for enabling 
an imaging-based quantification of tissue perfusion. To this 
end, arterial blood is used as an endogenous tracer, obviat-
ing the need for exogenous contrast agents. This particular 
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feature of ASL, combined with the lack of need to employ 
ionizing radiation, renders it a fully non-invasive and univer-
sally applicable technique, regardless of age and degree of 
renal impairment, and highly suited for applications where 
serial monitoring of perfusion is required. Furthermore, 
ASL delivers the added benefit of being able to measure 
perfusion of each kidney separately, as well as assess intra-
renal regional variations in perfusion. Its versatility makes 
it also perfectly feasible in kidney transplants, in spite of 
a very different vascular anatomy. Containing some of the 
most highly perfused tissue in the body, the kidneys were 
among the first organs where the feasibility of ASL to meas-
ure blood perfusion was reported [6]. However, in the first 
20 years since those initial experiments, ASL was mostly 
confined to the brain, as susceptibility effects and motion 
limited its use in thoracic and abdominal organs. Nonethe-
less, work in renal ASL has substantially increased in the 
past few years, motivated by the interest in avoiding the use 
of gadolinium-based contrast agents, particularly in patients 
with significant renal impairment [7]. The last decade saw 
major technical developments which were accompanied 
by initial forays into several clinical applications. Many of 
these, as they pertain to kidney imaging in humans have 
been recently reviewed by the PARENCHIMA renal ASL 
expert panel [8] and by other authors [9, 10]. These reviews 
provide a compilation of published studies and a summary 
of data available on the validation and reproducibility of the 
technique for the assessment of renal perfusion in healthy 
and diseased kidneys. Concurrent with this growing inter-
est, standardization of renal ASL methods is becoming cru-
cial, particularly to enable large-scale multicenter studies 
and clinical trials. Nevertheless, the number of degrees of 
freedom in technical parameters of an ASL protocol is such 
that non-expert users are faced with a large array of choices 
which makes starting a study daunting. Furthermore, even 
though ASL acquisition methods are available in all major 
MRI scanner vendors, a lack of focus on renal imaging as a 
primary target often results in a limited capability of even 
state-of-the-art scanners to readily perform renal ASL using 
standard, commercially available pulse sequences.
We believe that providing clear technical recommenda-
tions for setting up data acquisition and analysis protocols 
will promote a widespread adoption of renal ASL and ulti-
mately allow its potential for patient benefit to be realized 
sooner. This work aims to put forth a set of technical recom-
mendations for renal ASL from an international group of 
experts working under the framework of the PARENCHIMA 
project, funded by a European Cooperation in Science and 
Technology (COST) Action (CA16103). One of our aims 
with these recommendations is to provide inexperienced 
sites with a robust starting point from which a robust renal 
ASL protocol can be developed with minimal replication of 
effort. Our hope is not for these recommendations to be seen 
as the definitive protocol for renal ASL but rather as a set of 
guidelines that capture the current consensus of a wide range 
of expertise in the renal ASL community. Rather than stifle 
innovation, we aim to stimulate clinical research using ASL 
by providing a straightforward set of parameters for image 
acquisition for non-specialist centers and facilitating the 
standardization of methods across different sites. Further-
more, we hope that by identifying what we hypothesize to 
be the current issues which require future investigation, we 
will inspire the scientific community to address these gaps 
in knowledge, focusing and accelerating worldwide efforts to 
progress renal ASL into a clinically useful technique, where 
it holds potential to improve the diagnosis and management 
of kidney disease.
Previous literature review
One of the initial steps in the COST PARENCHIMA pro-
ject included an extensive literature review of renal ASL 
[8]. This work summarized 53 studies on human subjects 
(excluding renal cancer) published until January 2018. 
Issues such as repeatability and validation of ASL with alter-
native methods to measure renal perfusion were extensively 
addressed therewith and, therefore, will not be covered in 
the present manuscript. The previous literature review [8] 
as well as 12 studies published in the intervening period 
[11–22], the results of a series of surveys and the discussions 
that took place at the in-person meetings form the basis for 
the final recommendations presented here.
Variants of renal ASL and key parameters
In ASL methods, radiofrequency (RF) pulses are employed 
to alter the longitudinal magnetization of blood water, ren-
dering it a diffusible tracer. After allowing a time delay to 
ensure arrival of the “labelled” blood to the tissue micro-
vasculature, a “label” (or “tag”) image is acquired. In the 
next repetition time (TR), the image acquisition is repeated 
without prior labelling of the inflowing blood, yielding a 
“control” image. In both measurements, the static tissue 
spins have experienced the same magnetization prepara-
tion. Therefore, its signal contribution can be removed by 
subtracting the two resulting images. However, the differ-
ence in signal due to inflowing blood (which has undergone 
different preparations) remains unaffected by the subtraction, 
and a perfusion-weighted image is obtained. In practice, the 
pair of label and control acquisitions is repeated to ensure 
sufficient signal-to-noise ratio (SNR). The ASL sequence 
can be thought of as the combination of two modules, a 
magnetization preparation module and a readout module, 
which are virtually independent. The magnetization prepara-
tion consists of inverting arterial blood magnetization before 
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it reaches the tissue of interest. The effects of this inversion 
are detected by comparison with a control condition. This 
inversion can be realized using two main ASL variants: con-
tinuous and pulsed ASL (CASL and PASL, respectively) 
(see Fig. 1).
In CASL, blood magnetization is continuously inverted 
as it flows through a plane (the labelling plane). This con-
tinuous inversion is achieved by simultaneous application 
of a low-amplitude long-duration RF pulse and a gradi-
ent in the direction of flow, which causes the inversion of 
magnetization by adiabatic fast passage. Pseudo-continu-
ous ASL (PCASL) [23] is a variant of continuous ASL in 
which the continuous RF pulse and gradient are replaced 
by a large number of selective RF pulses of short duration 
(see Fig. 2). In the gaps between successive RF pulses, the 
selective gradient (Gmax) is only partially rephased, result-
ing in a net average gradient (Gave) applied during the total 
duration of the labelling that mimics the continuous gradient 
applied in CASL. Due to the presence of this average gradi-
ent, the phase of successive RF pulses must be incremented 
by 휙 = 훾GaveTZ , where 훾 is the gyromagnetic ratio, T  is 
the RF pulse spacing and Z is the position of the labelling 
plane with respect to the gradient isocenter so that they stay 
in phase with the flowing spins. During the control condi-
tion, the RF pulse train remains the same, thus cancelling 
magnetization transfer (MT) effects, except for the phase 
of successive RF pulses, which is incremented by 휋 radi-
ans. Two versions of PCASL have been proposed that dif-
fer in the control gradient waveform, named balanced and 
unbalanced PCASL. In balanced PCASL [24], the control 
Fig. 1  ASL timing diagram for CASL/PCASL and PASL, depict-
ing both control and label conditions. Labeling pulses are shown in 
purple and the orange block represents the readout. TR is the repe-
tition time. In CASL/PCASL: 휏 is the labeling time and PLD is the 
post-labeling delay. In the PASL scheme, the green block represents 
QUIPSSII type saturation pulses, TI1 is the bolus duration and TI is 
the inflow time
Fig. 2  PCASL labeling scheme, 
showing successive RF pulses 
and gradients. 훿 is the RF pulse 
duration, T  is the RF pulse spac-
ing, Gmax is the amplitude of 
the slice selection gradient and 
Gave represents the net average 
gradient
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gradient waveform is equal to that applied during the label, 
while in unbalanced PCASL [23], the selective gradient is 
totally rephased, resulting in a Gave equal to zero. The dura-
tion of the RF pulse train is referred to as the labelling time 
( 휏 ), while the time interval from the end of labelling to the 
beginning of the readout is known as the post-labelling delay 
(PLD). PCASL has lower MT effects than CASL and can be 
used to efficiently image multiple slices simultaneously. In 
addition, it is compatible with the hardware available in most 
clinical MRI systems and has, therefore, replaced CASL, 
since its inception.
In PASL, the magnetization of a large volume of arterial 
blood is inverted almost instantaneously through the applica-
tion of an inversion pulse. Multiple variants of PASL have 
been proposed; however, to date most renal ASL studies have 
used the flow-sensitive alternating inversion recovery (FAIR) 
approach [25, 26]. In FAIR, a non-selective adiabatic inver-
sion centered at the imaging plane is applied for the label 
acquisition while for the control acquisition, a slab selec-
tive inversion inverts the magnetization in a narrow volume 
including the imaging slice. Since the only difference between 
the label and control conditions is the application of the selec-
tive gradient, FAIR is insensitive to MT effects. In FAIR, the 
time interval from the labelling pulse to the readout is termed 
the inflow time (TI). In order to obtain a quantitative value 
of perfusion using this approach with a single TI acquisition, 
the time duration of the labeled bolus must be known. This 
is achieved by applying saturation pulses to clearly define the 
bolus duration (using a QUIPSSII scheme, corresponding to 
the Quantitative imaging of perfusion using a single subtrac-
tion, version II method [27], or Q2TIPS scheme—QUIPSS II 
with Thin-slice  TI1 Periodic Saturation [28]), in which satu-
ration pulses are applied at time  TI1 after the inversion pulse 
to destroy the tail end of the labeled bolus, thus effectively 
setting the bolus duration to be equal to  TI1.
Materials and methods
Description of survey process
The Delphi method [29] constitutes a group effort to effi-
ciently reach consensus on matters where quantitative 
evidence may be scarce, incomplete, or difficult to obtain. 
Details about the Delphi method can be found in numer-
ous publications (e.g. [30, 31]) and further specific details 
about the consensus-generation approach used in the COST 
PARENCHIMA project can be found in Mendichovszky et. 
al. [32]. An in-person meeting in Prague preceded the for-
mal start of the Delphi process allowing for attending panel 
members to start discussions and agree upon the method for 
generating recommendations [33]. The approach used for 
driving the consensus formation process included one initial 
preliminary survey and two “consensus” surveys [32, 34]. 
All surveys included questions focusing on obtaining techni-
cal recommendations to facilitate translation of renal ASL to 
the clinic and were divided into several categories: Patient 
preparation, Hardware, Labelling strategy, FAIR labelling 
parameters, PCASL parameters, Readout, Other sequence 
details, Data preprocessing and Quantification. The final 
survey (i.e. second consensus survey) additionally included 
a section on Data analysis/reporting. The preliminary survey 
[33] was set up with questions that allowed a combination of 
multiple-choice answers covering a broad range of settings 
for the main ASL parameters as well as open-ended ques-
tions. This allowed the panel co-chairs to draft an initial set 
of proposed statements already informed by the responses 
of the entire panel, which, to the extent possible, maximized 
the amount of initial consensus and minimized the number 
of further rounds necessary to refine statements for which 
consensus did not exist at the starting point.
The first set of draft consensus statements was then shared 
with the entire panel for scoring, where the possible replies 
were: "1: Strongly Disagree", "2: Disagree", "3: Neutral", "4: 
Agree", "5: Strongly Agree" [33, 35]. Respondents were asked 
to provide further details when disagreeing with any particular 
statement [35]. Consensus was assumed to be found when 
75% or more of respondents agreed with a particular state-
ment. Neutral responses were considered abstentions and were 
excluded from the calculation. The second in-person meeting 
took place after the scoring of the first set of consensus state-
ments to present results to the group and allow for discussion 
to modify/rephrase statements for which consensus had not 
been found [33–35]. Half of the respondents to the survey 
attended the second in-person meeting. The revised set of 
consensus statements was then rescored by the entire panel 
where the possible replies were: "I agree", "I disagree", "I 
have insufficient experience to make a recommendation" [34]. 
The latter was considered abstention and was removed from 
the consensus calculation. The threshold for consensus was 
also 75% (inclusive) of agreements. A summary of this pro-
cess is shown in Fig. 3. The complete list of questions which 
composed each survey is provided as supplementary material.
Panel characteristics
The panel comprised clinical and non-clinical research-
ers with expertise in renal ASL as evidenced by a previ-
ous track-record of publications and/or ongoing research in 
renal ASL, working in six countries and with backgrounds as 
follows: Engineer, 17%; Nephrologist, 4%; Physicist, 70%; 
Radiologist, 9% (background, percentage of total number 
of panel members; see Table 1). The degree to which panel 
members participated in the different stages of the Delphi 
consensus method is summarized in Table 1.
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Results
The response rate for the three surveys (preliminary + 2 
consensus surveys) was 74%, 70%, and 91%. Some of the 
researchers joined the panel and took part in the process 
after the second in-person meeting, which explains the 
lower response rate of the first two surveys. For most of 
the consensus statements, the percentage of agreement 
was much higher than the pre-established threshold of 
75%. Indeed, for 42% of statements the whole panel was 
in agreement. This shows that there is a clear convergence 
among experts regarding the basic technical aspects of 
renal ASL data acquisition and analysis. Overall, for the 
statements for which consensus was found the absten-
tion and agreement level were 12 ± 10% and 94 ± 7%, 
respectively.
Fig. 3  Overview of the consen-
sus formation process
Table 1  Panel characteristics 
and participation in consensus 
process; 0: no; 1: yes; S <n> : 
survey number “n”; IPM2: 
second in-person meeting
Panel member 
(#)
Country Background S0 S1 IPM2 S2
1 US Engineer 1 1 0 0
2 UK Nephrologist 0 0 1 0
3 DE Physicist 1 0 0 1
4 DK Physicist 0 0 1 1
5 US Physicist 1 1 0 1
6 UK Physicist 1 1 1 1
7 US Physicist 1 1 0 1
8 US Physicist 0 0 0 1
9 UK Physicist 0 0 0 1
10 US Physicist 0 0 1 1
11 ES Engineer 1 1 1 1
12 UK Physicist 1 1 1 1
13 UK Engineer 1 1 1 1
14 US Physicist 1 1 0 1
15 NL Engineer 1 1 1 1
16 US Physicist 1 1 0 1
17 UK Physicist 1 1 1 1
18 UK Physicist 1 1 0 1
19 US Physicist 1 1 0 1
20 DE Radiologist 1 1 1 1
21 US Physicist 0 0 1 1
22 US Radiologist 1 1 0 1
23 US Physicist 1 1 1 1
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Consensus statements
The 59 final consensus statements are listed in Table 2, 
as well as the abstention and agreement level for each 
statement.
In summary, as a default implementation, we recommend 
acquisition of coronal oblique ASL data at 1.5 T or 3 T using 
PASL (FAIR) or PCASL labelling at a single time point and 
using a 2D readout with background suppression. Examples 
of renal ASL images acquired from a healthy volunteer using 
such a protocol are shown in Fig. 4, together with the cor-
responding RBF map. Furthermore, examples of renal ASL 
data obtained in three patients with CKD can be seen in the 
supplementary material (Figure S1).
Lack of consensus
The statements for which consensus could not be reached are 
listed in Table 3. Both statements concerned patient prepara-
tion by dietary restrictions and are indirectly related to the 
technical setup of renal ASL protocols, the main area of 
focus of these recommendations.
Discussion
In this section, recommendations are numbered and can be 
identified by the prefix "R".
Patient preparation
The panel agreed that the subject should be scanned in a 
normal hydration state where appropriate [R1.1]. Measuring 
hydration status is challenging and there is no universally 
accepted reference standard measure [36, 37]. Standardizing 
patient preparation with the aim of achieving more reproduc-
ible renal perfusion measurements may be desirable. Renal 
ASL perfusion estimates have shown significant variation 
when subjects were challenged with water loading, protein 
load, adenosine, and furosemide [20, 38–40].
The large abstention level on some aspects related to 
patient preparation (see Table 3) may reflect uncertainty and 
a lack of definitive evidence in the literature with regard to 
these issues. It might also reflect the large variety of experts, 
not all nephrologists, and, therefore, not all capable of rec-
ommending on such aspects of patient preparation.
Hardware
The panel agreed that both 1.5 T and 3 T are adequate field 
strengths for renal ASL measurements [R2.1]. Imaging at 
3 T provides inherently higher SNR, which in ASL is further 
boosted by longer longitudinal relaxation times of the ASL 
label and renal tissue. However, susceptibility-induced  B0 
inhomogeneity is more pronounced increasing the propen-
sity to artefacts such as distortion and signal loss. Shorter 
T2* at 3 T compared to 1.5 T further contributes to signal 
loss. In addition, greater power deposition (which increases 
with the square of the  B0 field strength) may pose slice cov-
erage limits particularly in sequences with more intensive 
use of RF energy. Results of published studies in which 
renal ASL measures have been collected at field strengths 
of 1.5 or 3 T show a similar range of renal cortex perfusion 
values in healthy subjects and in renal disease and similar 
reproducibility [41, 42]. The panel agreed that a system-
integrated body coil should be used for RF transmission 
[R2.2] together with body phased-array receive coils [R2.3].
Labelling strategy
A consensus was reached that both pulsed ASL FAIR and 
PCASL schemes are adequate for renal ASL [R3.1]. For 
each, single time point acquisitions, defined to be at a given 
TI for FAIR and PLD for PCASL, are recommended for 
simplicity of acquisition and data analysis [R3.2]. Multi-
ple time point acquisitions, in which data are collected at a 
number of TIs [20, 43, 44] or PLDs [45], require a longer 
acquisition time and more complicated processing. However, 
it was agreed that a multiple time point method can be useful 
if delayed arrival time is suspected in a clinical population, 
as this provides a measurement of arterial transit time (ATT) 
which can facilitate more accurate quantification of renal 
perfusion [R3.3].
FAIR labelling parameters
In FAIR, control and label conditions are achieved by alter-
nating between a non-selective and selective inversion slab. 
The RF pulse used for the selective inversion should have 
sharp inversion profile edges, and an adiabatic frequency 
offset corrected inversion (FOCI) pulse [46, 47] is recom-
mended for this purpose [R4.1]. The selective inversion slab 
is placed in-line with the imaging slab and should be care-
fully positioned to exclude the feeding arteries (descending 
aorta for native kidneys) to avoid labelling of blood in the 
control condition resulting in the maximum signal differ-
ence between label and control conditions due to inflowing 
blood (i.e. to maximize perfusion signal) [R4.2] (see Fig. 5). 
The thickness of the selective inversion slab should equal 
the imaging slab with an addition of 10–20 mm to avoid a 
mismatch between the location of the selective inversion 
slab and imaging slab (e.g. due to motion in the time (TI) 
between labelling and readout) [R4.3]. The choice of added 
thickness is determined particularly by the available space 
between the selective inversion slab and the aorta which 
is also dependent on the number of imaging slices being 
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Table 2  Final consensus statements
# Statement Absten-
tions 
(%)
Agreement (%)
1. Patient preparation
1.1 Subject should be scanned in a normal hydration status when clinically appropriate 24 100
2. Hardware
2.1 Both 1.5 T and 3 T are adequate field strengths 0 87
2.2 The body coil should be used as transmitter coil 6 93
2.3 Body phased-array coils should be used as receive coils 0 94
3. Labeling strategy
3.1 Both PASL:FAIR and PCASL are adequate labeling strategies 6 93
3.2 Single time point acquisitions are recommended for simplicity of acquisition and data analysis 6 86
3.3 Multiple time point acquisitions require a longer acquisition time and more complicated processing. However, 
they can provide measurements of perfusion and ATT that can be useful if delayed arrival time is suspected in 
a clinical population
6 100
4. FAIR labeling parameters
4.1 A FOCI pulse should be used for the selective inversion to optimize the inversion slice profile 19 92
4.2 The selective slab should be carefully positioned, excluding the aorta 6 100
4.3 The selective inversion slab thickness should equal the imaging slab thickness + [10–20] mm 13 86
4.4 In single-TI acquisitions, an inversion time of 1.8–2.0 s is recommended 10 89
4.5 In single-TI acquisitions, an approach for controlling the temporal width of the bolus (QUIPSS II or Q2TIPS) 
must be used to quantify perfusion
25 100
4.6 A bolus duration  (TI1) of 1.0–1.2 s is recommended 25 92
4.7 In single-TI acquisitions, a minimum of 20 ASL pairs is recommended 10 89
5. PCASL parameters
5.1 An unbalanced version of PCASL is preferred due to its lower sensitivity to off-resonance effects 38 80
5.2 A labeling time of 1.5–1.8 s is recommended 10 100
5.3 The labeling plane should be oriented approximately perpendicular to the aorta 13 100
5.4 The labeling plane should be positioned at approximately 8–10 cm from the centre of the kidney, in the supe-
rior direction
14 94
5.5 Hanning RF pulses are recommended 31 100
5.6 An RF pulse duration of 500 μs is recommended 25 100
5.7 Pulse spacing (from the centre of one pulse to the centre of the next) of 1000 μs or shorter is recommended 31 100
5.8 Average  B1 of 1.6 μT is recommended 27 100
5.9 Average gradient (Gave) of 0.4–0.6 mT/m is recommended 25 92
5.10 Gmax to Gave Ratio of 6–7 is recommended 40 100
5.11 In single PLD acquisitions, a PLD of 1.2–1.5 s is recommended 19 100
5.12 In single-PLD acquisitions, a minimum of 20 ASL pairs is recommended 14 83
6. Readout
6.1 A 2D single-slice acquisition scheme is recommended as the default renal ASL method 10 95
6.2 Multislice 2D acquisition schemes are recommended for applications that require extended kidney coverage 5 100
6.3 3D acquisition schemes represent a promising alternative to 2D multislice schemes but are not recommended as 
the default method for extended kidney coverage due to limited clinical experience with 3D schemes
10 95
6.4 Spin-echo EPI is the preferred readout for 2D single-slice acquisitions 5 75
6.5 bSSFP and single-shot RARE are adequate alternatives to EPI for 2D single-slice acquisitions 14 94
6.6 Spin-echo EPI is the preferred readout for 2D multislice acquisitions 14 83
6.7 Coronal oblique slices (along the major axis of the kidneys) are preferable for renal ASL 6 93
6.8 The recommended slice thickness in 2D acquisitions is 4-8 mm 19 100
6.9 The recommended slice thickness in 3D acquisitions isss 3-6 mm 13 100
6.10 The recommended in-plane resolution is 2-4 mm 0 93
6.11 Undersampling methods, such as partial Fourier and parallel imaging at moderate acceleration factors (up to 
R = 2) may be used
19 100
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acquired. A TI of 1.8–2.0 s is recommended in single-TI 
acquisitions [R4.4] to allow sufficient time for the labeled 
blood to arrive at and exchange with the renal parenchyma 
(see Figure S2 in the supplementary material). Previous 
studies in healthy volunteers have mostly used somewhat 
shorter TIs, but studies in patients often have used a longer 
TI of ~ 2 s [19, 48, 49]. At 1.5 T the more rapid  T1 decay of 
the label should be taken into account in the choice of TI. To 
quantify renal blood flow, the temporal width of the bolus 
should be defined. This can be achieved by the application 
of saturation pulses (QUIPSSII [50] or Q2TIPS [28]) at the 
location of the feeding arteries with a certain delay time 
after the FAIR labelling pulse (referred to as bolus duration 
or  TI1) [R4.5]. A bolus duration  (TI1) of 1.0–1.2 s is recom-
mended [R4.6] to allow sufficient labelled blood to enter 
the tissue before the tail of the bolus is saturated such that 
it no longer contributes to the perfusion signal. To improve 
SNR, multiple ASL pairs (control and label images) are 
acquired during a scan. The acquisition of a minimum of 
20 ASL pairs (control and label images) when using the 
recommended 2D readout is advised to obtain an averaged 
perfusion weighted image with sufficient SNR [R4.7].
PCASL parameters
The PCASL parameters recommended here have been cho-
sen with the objective of maximizing labelling efficiency 
while increasing the robustness of the labelling in the pres-
ence of magnetic field  B0 variations over the region of the 
labelling plane. Both versions of PCASL (balanced and 
Table 2  (continued)
# Statement Absten-
tions 
(%)
Agreement (%)
6.12 The recommended TR (including labeling + readout) is 4–6 s 0 94
7. Other sequence details
7.1 Pre and post-inversion saturations are recommended for FAIR labeling schemes 14 100
7.2 Background-suppression is recommended for renal ASL 5 80
7.3 Breath-hold scans are not recommended for clinical renal ASL 0 94
7.4 Renal ASL scans under free breathing are preferred 0 76
7.5 Respiratory triggering can be advantageous to minimize the effects of kidney motion at the expense of scan 
time
5 95
7.6 Fat suppression is recommended for renal ASL 5 90
8. Data preprocessing
8.1 Retrospective image registration is highly recommended for renal ASL 13 100
8.2 Outlier rejection is recommended for renal ASL 0 100
9. Quantification
9.1 M0 acquisition is mandatory 0 94
9.2 Using a single-compartment model with assumed blood  T1 for quantification is recommended for robustness 
and simplicity
7 100
9.3 A two-compartment model with separate transit time and tissue  T1 measurements is a viable alternative to the 
single-compartment approach but requires more complex acquisition/analysis methods and therefore is cur-
rently not recommended as the default renal ASL approach
10 95
9.4 Tissue-blood partition coefficient = 0.9 mL/g [82–84, 97] 5 90
9.5 Assumed blood  T1 at 3 T = 1.65 s [98] 0 100
9.6 Assumed blood  T1 at 1.5 T = 1.48 s [98] 13 93
9.7 Labeling efficiency PASL = 95% (neglecting background suppression loss) 6 100
9.8 Labeling efficiency PCASL = 85% (neglecting background suppression loss) 13 86
9.9 When background suppression is used, the labeling efficiency needs to be adjusted based on the number of 
background suppression pulses
19 100
9.10 Regions of interest selection should be performed manually as the default approach. Semi-automatic methods 
may be used if local expertise is available (e.g. using  T1 maps) but require extensive validation
0 100
9.11 Region of interest selection should be performed based on the ASL  M0 image or a separately acquired struc-
tural dataset
6 93
10. Data analysis/reporting
10.1 Cortical renal blood flow values (not whole-kidney) should be reported, separately for left and right kidney 0 100
10.2 Medullary renal blood flow values are not considered reliable with current measurement approaches 14 89
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unbalanced) have been successfully employed in renal ASL; 
however, recent work has demonstrated greater robustness of 
unbalanced PCASL to off-resonance effects [51]. Although 
this work was done in the context of brain ASL, the same 
results would be expected when labelling the aorta, where 
magnetic field variations are likely to be more pronounced 
than in the carotid arteries, due to the proximity of the lungs 
and vertebral column. Although both approaches have not 
yet been directly compared in the kidney extensively, the 
unbalanced implementation of PCASL is considered pref-
erable to the balanced implementation [52], if available 
[R5.1]. The efficiency of PCASL increases with the average 
 B1 amplitude of the labelling RF pulses; however, in practice 
the  B1 amplitude is restricted by specific absorption rate 
(SAR) limitations. The recommended value of 1.6 µT should 
provide high efficiency while keeping SAR within accept-
able safety limits [R5.8]. It is worth emphasizing that this 
value represents the average value over the time (see Fig. 2), 
not the RF pulse peak amplitude. Hanning-shaped RF pulses 
Fig. 4  Example of renal ASL data from a healthy volunteer acquired 
at 3  T using the recommended protocol. Top row images were 
obtained with PCASL and bottom row with PASL (FAIR) labeling: 
a, e control; b, f label; c, g mean perfusion-weighted image; d, h RBF 
map. Data were acquired using background suppression (3 pulses), 
followed by a SE-EPI readout
Table 3  Statements for which consensus was not found
# Statement Absten-
tions 
(%)
Agree-
ment 
(%)
1. Patient preparation
A Diet needs to be controlled before the scan 43 50
B Subjects are required to follow a controlled 
and standardized salt intake before the 
scan
48 27
Fig. 5  Positioning of the FAIR selective inversion slab (in purple), imaging slice (in orange) and QUIPSSII/Q2TIPS type saturation slab (in 
green) is shown on anatomical localizers in the coronal, axial and sagittal orientations
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of 500 µs duration are recommended to improve the spatial 
selectivity of the RF pulse train [R5.5, R5.6]. The pulse 
spacing ( T  ) (time from the center of one pulse to the center 
of the next) should be kept as short as possible to decrease 
the sensitivity to resonance frequency offsets. Due to duty 
cycle constraints, in most scanners the pulse spacing cannot 
be shorter than 1 ms [R5.7]. Gave values of 0.4 to 0.6 mT/m 
are recommended [R5.9]. These values maximize labelling 
efficiency for the pulsatile velocity waveform characteristic 
of blood flow at the abdominal aorta [53]. A ratio of selec-
tive to average gradients, Gmax/Gave, of 7 is recommended 
[R5.10]. This ratio, lower than previously proposed for brain 
ASL [54], has been shown to improve off-resonance label-
ling [51]. However, a lower ratio results in a wider labelling 
region and, therefore, care must be taken when positioning 
the labelling plane (as discussed next).
The labelling plane should be positioned carefully, ori-
ented approximately perpendicular to the aorta [R5.3] (see 
Fig. 6), and positioned above the highest kidney (to prevent 
direct saturation), while avoiding intersecting the heart. 
If allowed by anatomical constraints, it should be placed 
below the lungs to minimize off-resonance effects. A dis-
tance of 8–10 cm from the center of the highest kidney is 
recommended to fulfil these conditions in most cases [R5.4], 
although the optimal position will be determined by the spe-
cific patient size and anatomy.
A labelling duration of 1.5–1.8 s is recommended [R5.2] 
[11, 21, 55–59]. Longer labelling durations would provide 
higher SNR for a given image, but would also lengthen the 
TR, reducing the number of averages acquired per unit time 
and increasing the power deposition. A PLD of 1.2–1.5 s is 
recommended in single PLD acquisitions [R5.11] [11, 21, 
55, 57–60]. This PLD should allow for all the labeled blood 
to arrive at the renal parenchyma before image acquisition 
in most subjects, thus providing perfusion weighted data 
which can be quantified to yield quantitative renal blood 
flow values. This PLD is longer than the analogous quantity 
TI–TI1 in PASL to compensate for the longer transit delay in 
PCASL compared to PASL [50]. For some patient popula-
tions, where ATT could be abnormally long (such in the case 
of renal artery stenosis) a longer PLD could be desirable; 
however, lengthening the PLD would also lead to decreased 
SNR due to  T1 decay. Finally, the acquisition of a minimum 
of 20 ASL pairs (control and label images) when using the 
recommended 2D readout is advised to obtain an average 
perfusion weighted image of sufficient SNR [R5.12].
Readout
An important consideration for renal ASL is the choice of 
readout scheme. The intrinsically low SNR of ASL neces-
sitates high SNR readout schemes. However, due to the rapid 
decay of the ASL signal, the readout time must be short. The 
optimal ASL readout scheme should have a short echo time 
(TE) in order to provide the highest image SNR and reduce 
the amount of signal loss and distortions. Short image acqui-
sition times are particularly important in multislice acqui-
sitions, so that a short temporal spacing can be achieved 
between multiple slices allowing the volume to be acquired 
prior to the decay of the ASL signal.
The first consideration is whether a single or multislice 
readout scheme should be used. A consensus was reached 
that a single-slice acquisition scheme is recommended as 
the default renal ASL method [R6.1]. This recommenda-
tion was motivated by the robustness and reproducibility of 
single-slice acquisitions, which are easier to plan, especially 
when combined with FAIR labelling, and the fact that back-
ground suppression of the static tissue can be optimized for a 
single time point only. Moreover, acquisition of single-slice 
perfusion data was considered sufficient in most patholo-
gies where kidney dysfunction is widespread and affects the 
whole kidney in a uniform manner. Exceptions to this would 
be cases in which renal dysfunction is due to unilateral and/
or focal lesions due to vascular, tumoral, obstructive or 
infectious causes. Examples include certain causes of acute 
kidney injury such as sepsis and renal papillary necrosis 
caused by nonsteroidal inflammatory drugs [61]. In cases 
such as these where extended kidney coverage is required, 
it is recommended to use a multislice 2D acquisition scheme 
[12] [R6.2], although in this case, the degree of background 
Fig. 6  Positioning of the PCASL labeling plane (in purple) and imaging slice (in orange) is shown on anatomical localizers in the coronal, axial 
and sagittal orientations
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suppression will vary across slices. It was recognized that 
3D acquisitions represent a promising alternative to 2D mul-
tislice schemes that can be optimally combined with BGS 
[14, 21], but are at this time not recommended as a default 
method due to limited clinical experience with these tech-
niques [R6.3].
For a 2D readout scheme, this survey asked participants 
to choose between balanced steady-state free precession 
(bSSFP) [62], spin-echo echo-planar imaging (SE-EPI) [63], 
and single-shot rapid acquisition with relaxation enhance-
ment (RARE) [55, 64]. Gradient-echo echo planar imaging 
(GE-EPI) was not considered because of its susceptibility 
to the magnetic field inhomogeneities that are present in 
abdominal regions. A bSSFP readout has the advantage of 
high image SNR and a very short echo time (TE) but has a 
long image acquisition time and temporal image spacing 
due to SAR constraints. This limits the number of slices 
that can be acquired before signal decay of the label, ren-
dering bSSFP suboptimal for applications where multiple 
slices are required. A bSSFP scheme is also sensitive to field 
inhomogeneity, which results in banding artefacts in areas 
of off-resonance within the image. A SE-EPI sequence has 
the advantage of rapid acquisition allowing multiple slices 
to be acquired at the peak of the ASL signal curve lead-
ing to low variance in the perfusion-weighted signal across 
slices. However, due to the large field of view (FOV) gen-
erally used in body imaging, EPI readouts can have a long 
echo time (TE) which limits their use for high-resolution 
imaging. SE-EPI readouts are also susceptible to chemical 
shift artefacts (e.g. from fatty tissue) (see Figure S2 in the 
supplementary material). A RARE readout scheme provides 
high image SNR and has low susceptibility-induced signal 
loss. However a 2D RARE readout has a long TE, echo train 
duration and high SAR due to the multiple refocusing pulses. 
This results in a long temporal slice spacing for multislice 
imaging, limiting the number of slices achievable at the peak 
of the ASL signal. Taking into consideration the aforemen-
tioned reasons, and the widespread availability across scan-
ner vendors, a consensus was reached that SE-EPI is the 
preferred readout scheme for 2D single-slice imaging [R6.4] 
and multislice [R6.6] acquisitions, with bSSFP and single-
shot RARE considered adequate 2D single-slice alternatives 
[R6.5]. A consensus was reached that coronal oblique slices 
(along the major axis of the kidneys) are preferable for renal 
ASL [R6.7]. For FAIR, this is necessary to avoid labelling 
of the inflowing vessels for the selective label. A coronal 
oblique orientation also has the advantage that most kidney 
movement due to the respiratory cycle is within the image 
plane and so data can be corrected using image registra-
tion methods. In addition, if full coverage is required, fewer 
slices are needed in coronal oblique scans.
For a 2D acquisition, the recommended slice thickness is 
4–8 mm [R6.8], whereas for a 3D readout the recommended 
slice thickness is 3–6 mm [R6.9]. Consensus was reached 
for an in-plane resolution of 2–4 mm [R6.10]. The use of 
undersampling methods such as partial Fourier and parallel 
imaging is recommended to reduce TE and readout time and 
thus minimize susceptibility-induced geometric distortions, 
signal loss and blurring. Low acceleration factors up to 2 
are preferred because higher acceleration leads to SNR loss 
which is not desirable since ASL is SNR-limited [R6.11]. 
The recommended TR (including labelling and readout) is 
4–6 s [R6.12].
Other sequence details
Throughout the development of ASL, a number of pulse 
sequence modifications have been introduced that aim to 
improve perfusion measurements by minimizing systematic 
errors that introduce variance in the ASL difference signal 
unrelated to tissue perfusion. Such errors can be caused by 
imperfect inversion profiles between the label and control in 
the FAIR scheme and/or MT effects of the labelling on the 
tissue in the imaging slice. These errors can be addressed 
by applying pre- and post-saturation pulses to the imaging 
volume [65, 66], and their use is recommended for FAIR 
[R7.1] and can also be applied to reduce the background 
signal variance in PCASL. ASL is challenged by the fact that 
the proportion of perfusion-weighted signal from inflowing 
labelled blood is low (on the order of 5% in healthy kidneys) 
compared to the static tissue signal. As such, fluctuations 
in the static tissue signal can overwhelm the perfusion-
weighted signal and thus bias perfusion estimates. Back-
ground suppression (BGS) was proposed to reduce signal 
from static tissue and thereby the deleterious effects of these 
fluctuations [67]. This is achieved with the use of multiple 
carefully timed inversion pulses to significantly reduce the 
longitudinal magnetization of static tissue at the instant of 
data acquisition [68]. BGS is used widely and is currently 
recommended for ASL in neuroimaging [54]. In the kidneys, 
initial studies by Robson et al. [55]. and Gardener et al. [63] 
demonstrated an improvement of ASL image quality when 
using BGS. However, the latter reported that in the body, in 
the presence of respiratory motion, this improvement was at 
the expense of SNR when compared to using image regis-
tration. Nevertheless, recent studies have demonstrated the 
capability of BGS to improve the temporal signal-to-noise 
ratio (tSNR) and image quality of ASL data and shown 
image registration to be effective even in data acquired with 
heavy BGS [11, 21]. For these reasons, we recommend the 
use of BGS for renal ASL [R7.2], and generally 2 to 4 BGS 
adiabatic inversion pulses have been employed in previous 
studies. It is worth noting that any inefficiency in the inver-
sion pulses used in the BGS scheme reduces the ASL dif-
ference signal [69] which should be accounted for in the 
quantification stage (see below) and suggests a balance has 
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to be struck between the number of BGS pulses used for 
effective reduction of static tissue signal fluctuations and 
labelling efficiency.
Subject breathing induces kidney displacements up to an 
order of magnitude larger than the typical ASL voxel size, 
which if unaccounted for cause a significant loss of image 
quality in ASL. Breath-holding effectively reduces kidney 
motion due to respiration but to compensate for the intrinsi-
cally low SNR of ASL measurements, acquisitions require 
either numerous or lengthy breath-holding periods, which 
can be challenging for patient populations [70–72] and even 
healthy volunteers [38]. Therefore, breath-hold scans are not 
recommended for clinical renal ASL [R7.3] and scans under 
free breathing are preferred [R7.4]. Respiratory triggering 
methods have been widely used in renal ASL [16, 18, 43, 44, 
58, 73] (among others) and can reduce motion artefacts in 
free breathing scans but at the expense of scan time [R7.5]. 
Respiratory coaching, where subjects are instructed to 
breathe during the periods when no data are being acquired 
(i.e. time gaps between acquisition of control and label data), 
have also been used to reduce motion artefacts [55, 57, 62, 
74]. External hardware (e.g. bellows) can be used to monitor 
patient compliance. However, the success of this approach 
depends on the degree of cooperation of the subject [74], 
which can limit the applicability of this technique in routine 
clinical scans.
Even though the degree to which fat suppression is 
required varies depending on the chosen type of image read-
out, in general, we recommend the use of fat suppression 
in renal ASL to avoid artefacts caused by the displacement 
of MRI signal from fatty tissue [R7.6]. This recommenda-
tion is particularly important for readout schemes with a 
low phase-encoding bandwidth, such as the aforementioned 
recommended EPI readout.
Data preprocessing
Preprocessing methods retrospectively improve data qual-
ity prior to perfusion quantification. Advantages of these 
methods are that they typically do not involve extra patient 
preparation or an increase in scan time, but in some cases 
require local expertise and/or can be time-consuming.
The standard preprocessing operation in ASL data is 
voxelwise signal averaging of the multiple control-label 
measurements acquired at a single TI (in PASL) or PLD (in 
PCASL). This addresses the inherently low SNR of ASL 
data and provides a degree of motion robustness provided a 
significant fraction of the ASL data is acquired with the kid-
neys at a consistent position. Other preprocessing methods 
in renal ASL aim to remove or downweight outlier measure-
ments or correct corrupted individual perfusion weighted-
images, most frequently caused by subtraction errors due 
to kidney motion (see Figure S2 in the supplementary 
material). Outlier rejection methods, including retrospec-
tive sorting of renal ASL data, have relied on manual [44, 
56, 62] or automatic [18, 58] approaches, including using 
data from external sensors such as respiratory bellows [55, 
63]. Outlier rejection methods have been shown beneficial 
to improve the data quality and, therefore, are recommended 
for renal ASL [R8.2].
Another class of preprocessing methods are motion cor-
rection techniques typically based on image registration, 
which can be used in conjunction with outlier rejection. 
These methods are widely used in renal ASL [11, 18, 63, 75, 
76] (among others) to realign the kidneys and ensure their 
position is consistent throughout the ASL time series and, 
therefore, reduce subtraction errors. They have been shown 
to reduce image artefacts, reduce partial volume effects 
between cortex and medulla, and improve the SNR of the 
perfusion-weighted signal and the repeatability of perfusion 
measurements. As such, retrospective image registration is 
highly recommended for renal ASL [R8.1]. Note that the 
kidneys should be registered separately if using rigid/aff-
ine transformations as they move independently [77, 78]. 
In addition, these methods should be used to not only align 
ASL control and label images but also any calibration scans 
[18, 21], such as  M0 data (essential for quantification) and 
optional  T1 data (acquisition of which is currently not rec-
ommended as part of the default renal ASL protocol). Extra 
care should be taken when aligning the ASL data to the 
calibration data (particularly if BGS is used) due to differ-
ences in image contrast which can reduce the accuracy of 
registration algorithms. Smoothing the  M0 data may reduce 
the impact of misregistration on perfusion quantification [54, 
79]. Methods to address this issue directly have been pro-
posed (e.g. [11].) but since they require further validation 
and/or changes to the acquisition scheme, they are currently 
not recommended.
Quantification
Quantifying perfusion images in physiologic units is an 
important step in the processing of ASL. Accurate quantifi-
cation enables comparison of values across scans, subjects, 
MR scanners, and even non MRI blood flow measurement 
techniques. Ideally, quantification also removes sensitivity 
to technical and physiologic factors not directly related to 
perfusion. Methods for quantification of renal perfusion 
draw heavily on the wider experience with ASL in the brain 
[27, 54, 80, 81]. These methods relate the control-label 
signal differences calculated above to a model for the sig-
nal dependence on tissue perfusion. As with most models 
of measurements in biological systems, there is a tradeoff 
between measurement feasibility and the greater model-
ling accuracy provided by more complex models. Concur-
rently, efforts in improving accuracy may be hampered by 
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inherent random variability in the data which in the presence 
of complex models may yield noisier parameter estimates. 
Here, we recommend quantification using a simpler model 
for the ASL signal that requires very few additional meas-
urements. This model neglects MRI signal relaxation dif-
ferences between blood and tissue so it is referred to as a 
single-compartment model. An advantage of this model, and 
our recommended single delay acquisition approach [R9.2], 
is that the tissue perfusion at each image voxel can be calcu-
lated directly by an equation, without iterative fitting. The 
equation to calculate renal perfusion (commonly referred to 
as renal blood flow, RBF), for PCASL is:
while for FAIR with QUIPSSII type saturation to shape 
the bolus the corresponding equation is:
Note that RBF is closely related to renal plasma flow 
(RPF), RPF = ( 1− Hct)*RBF, the latter typically estimated 
in Para-aminohippurate (PAH) clearance studies. In these 
equations: T1,blood is the MR longitudinal relaxation time of 
arterial blood, assumed to be constant across subjects and 
recommended to be 1.65 s at 3 T [R9.5] and 1.48 s at 1.5 T 
[R9.6] acquisitions, SI with the respective subscripts rep-
resents the signal of the control, label, and proton density 
(PD) images (see below), 훼 is the assumed labelling effi-
ciency [R9.7, R9.8], and 휆 is the assumed constant value for 
the tissue–blood partition coefficient, defined as the grams 
of water per gram of tissue divided by the grams of water 
per mL of blood. Since a reliable reference for the partition 
coefficient value in kidney was not known to this group, 
we recommend the use of a value of 0.9 mL/g [R9.4], the 
average value for brain tissue. Indeed, literature on water 
content in the renal cortex suggests the value of 0.9 mL/g to 
be a good approximation for the partition coefficient value 
in kidney [82–84]. Since this is a constant factor across the 
image, perfusion values calculated with this assumption 
could be readily corrected when a more accurate value of 휆 
is known. PLD and 휏 are the postlabelling delay and label-
ling duration of the PCASL acquisition, while TI and TI1 
are the inversion time and bolus duration of the QUIPSSII/
Q2TIPS type acquisition. If multiple slices are acquired with 
an echo-planar acquisition, PLD or TI will be longer for later 
acquired slices. These values should be determined for a 
given slice by incrementing the PLD or TI for the first slice 
(1)
RBF =
6000 ⋅ 휆 ⋅
(
SIcontrol − SIlabel
)
⋅ exp
(
PLD∕T1,blood
)
2 ⋅ 훼 ⋅ T1,blood ⋅ SIPD ⋅
(
1 − exp
(
−휏∕T1,blood
))
[
mL∕100 g∕min
]
,
(2)
RBF =
6000 ⋅ 휆 ⋅
(
SIcontrol − SIlabel
)
⋅ exp
(
TI∕T1,blood
)
2 ⋅ 훼 ⋅ TI1 ⋅ SIPD[
mL∕100 g∕min
]
with the (slice number − 1) × slice acquisition interval . The 
efficiency, 훼 , should be multiplied by an additional factor 
of 0.93 for each BGS inversion pulse added [R9.9] [69]. 
All recommended values are provided in Table 2. Scaling 
the perfusion-weighted signal into quantitative units (typi-
cally mL/100 g/min) requires estimation of the equilibrium 
magnetization in fully relaxed arterial blood. This is typi-
cally estimated from a separately acquired PD image and 
the aforementioned tissue–blood partition coefficient. As 
such, we consider acquisition of a separate PD image (also 
referred to as M0 image) a mandatory step for ASL quanti-
fication [R.9.1]. The PD image should be acquired without 
labelling or BGS and using a similar readout and acquisi-
tion parameters, with the exception that a long TR should 
be used. If this image is acquired without waiting for a suf-
ficiently (> 5 s) long recovery time (TR), the SIPD should 
be corrected for incomplete relaxation using the equation:
where T1,tissue is an estimate of the kidney  T1.
For quantitative assessment of renal perfusion, we recom-
mend region of interest (ROI) analysis to estimate an aver-
age perfusion value from the quantitative perfusion map 
[R9.10]. Renal cortex perfusion is most reliable, because its 
flow is high and the cortex tends to be more distant from the 
collecting system and major arteries that can cause artifacts 
on ASL. ROIs should be drawn manually on an anatomic 
image to avoid biases, either the PD image or a spatially 
registered higher resolution anatomic image [R9.11]. Semi-
automatic methods may be used if local expertise is avail-
able (e.g. using  T1 maps) but require extensive validation. 
ROIs should be adjusted to avoid hyperintense signals on 
the perfusion image as they likely represent vessels. Medul-
lary perfusion is difficult to measure reliably [56] [R10.2] 
because of its lower perfusion (and, therefore, lower signal) 
and close proximity to cortex which makes it susceptible 
to partial volume contamination. The kinetics of labelled 
water are also uncertain because arterial water is divided 
between filtrate and smaller arterioles. This water may also 
exchange with surrounding tissue before penetrating deep 
into the medulla. In spite of the above mentioned issues, if 
an estimate of medullary perfusion is of interest it would be 
critical to carefully select ROIs to include sufficient medul-
lary voxels to improve statistical power while attempting 
to minimize partial volume effects, as well as potentially 
increasing scan time (averaging) to boost SNR.
The recommended single-compartment model and quan-
tification method neglects a range of effects that the panel 
considered too complicated to measure in a typical clini-
cal research or clinical study at the current experience level 
with renal ASL. Importantly, we neglect the difference in  T1 
(3)SIPD,corr =
SIPD
1 − exp(−TR/T1, tissue)
,
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between blood and renal tissue. This is justifiable because 
the difference is not very large and the assumption of equal 
 T1 greatly simplifies the equation. Though quantification of 
 T1 is also an important method for renal characterization 
with ASL, including the subject or even voxel-specific value 
of  T1 would also require measurement of the time after label-
ling when blood water exits the microvasculature and enters 
the tissue. Measurement of arrival kinetics by multiple delay 
or TI acquisition and quantification by fitting a two-compart-
ment model with separate transit time and tissue  T1 meas-
urements is a viable alternative to the single-compartment 
approach but requires more complex acquisition/analysis 
methods and, therefore, is currently not recommended as the 
default renal ASL approach [R9.3]. We also assume ranges 
of transit times from the labelling region to the tissue that are 
sufficient for the equations above to be valid.  T1 of blood can 
vary across subjects and time, especially with differences in 
haematocrit [85], and kidney water content may change with 
pathology, affecting the quantification through  T1 [44] and 
the tissue–blood partition coefficient. As such, care should 
be taken in the interpretation of RBF measurements, or when 
comparing longitudinal RBF measurements, in conditions 
where the haematocrit is likely to change (e.g. anemia). The 
efficiency of labelling may also vary across subjects and 
time, especially if there are large changes in aorta and renal 
artery blood flow velocities.
Though we have recommended the use of saturation to 
define the bolus duration in pulsed labelling [18, 86], many 
studies of renal perfusion with pulsed ASL have not included 
this saturation. Quantification is typically performed by 
replacing  TI1 with TI in the RBF equation [63, 87]. This 
approach maximizes signal but will underestimate flow by 
a transit time-dependent factor.
Several imaging studies have shown that a lower cortical 
thickness is associated with reduced renal function as meas-
ured by eGFR [88–91]. In the case of advanced disease, the 
reduction in cortical thickness can be severe enough such 
that it approaches the typical dimensions of the ASL vox-
els, significantly reducing the number of pure cortex voxels 
from which cortical RBF can be estimated. The mixing of 
perfusion signal from the cortex with medullary signal may 
bias cortical RBF estimates to lower values (i.e. potentially 
causing an apparent reduction of cortical perfusion). Partial 
volume correction methods can be helpful in addressing 
this issue. However, the current lack of thoroughly tested 
(especially in renal ASL) and user-friendly partial volume 
correction methods hinders their widespread use. Therefore, 
cortical RBF results from ASL should be interpreted with 
caution in cases where cortical thinning is evident [92].
Data analysis/reporting
A recent systematic review of the renal ASL literature high-
lighted wide variation in how renal ASL data were reported 
making it difficult to compare and evaluate studies [8]. A 
strong agreement among the panel (81–100%) was found 
for reporting the general and ASL-specific parameters sum-
marized in Table 4.
There was also consensus that a minimum of mean and 
standard deviation of cortical renal ASL perfusion values 
should be reported at the subject (i.e. ROI analysis) or group 
level. The median should also be considered in the presence 
of skewed RBF distributions. Values for the right and left 
kidney should be reported separately [R10.1]. At the time of 
writing, the panel could not yet recommend reporting med-
ullary perfusion values by ASL due to poor reproducibility 
but noted that this was an area of active research [R10.2].
Transplants
This section describes specific aspects that should be taken 
into account for ASL of transplant kidneys that are different 
from the recommendations described above for native kid-
neys. There is a promising translational potential for func-
tional renal MRI in the transplanted kidney given that 28% 
of deceased donor and 15% of living donor kidneys will 
undergo chronic rejection within 5 years [93] and biopsy 
monitoring is invasive and with limitations such as sampling 
bias. Specifically, functional renal MRI has shown promis-
ing results for detection of acute tubular necrosis (ATN) [94] 
and longitudinal decline in renal perfusion within the first 
2 years of transplant [73].
Most commonly, the transplanted kidney is placed in 
the lower abdomen near the (right) iliac fossa and the renal 
artery and vein are connected to the external iliac artery 
and vein, respectively. The kidney body orientation varies 
and is atypical when transplanted to the lower abdomen 
making the transplant setting unique for renal ASL. In 
Table 4  Minimum set of parameters to be reported in ASL studies
General MR parameters Scanner manufacturer/model, receive coil type, pixel bandwidth, fat suppression, field of view, magnetic field 
strength, flip angle, image orientation, in-plane resolution, number of slices, parallel imaging (technique and accel-
eration factor), partial Fourier, physiological triggering/gating, readout pulse sequence type, slice gap, slice ordering, 
slice thickness, echo time, repetition time
ASL-specific parameters Background suppression, Inflow time(s)/post-labeling delay(s), labeling duration, labeling type, number of averages, 
quantification model
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the native kidneys, the renal arteries commonly follow a 
horizontal or slightly downward trajectory (i.e. flow direc-
tion is medial-to-lateral). The frequent oblique orientation 
of the artery for the renal allograft after transplantation 
is such that the direction of flow in this vessel is both 
medial-to-lateral and inferior-to-superior (i.e. caudo–cra-
neal) (see Fig. 7). The direction of flow in the iliac artery 
remains craneo–caudal after transplantation. However, the 
baseline flow from the iliac artery likely changes the abso-
lute perfusion of the transplanted kidney compared to the 
native kidney, biasing absolute perfusion towards lower 
values [73]. The lower abdomen and transplanted kidney 
are much less influenced by breathing motion compared to 
native kidneys, making respiratory gating/triggering less 
important for ASL in the transplant setting.
However, anatomical orientation of the kidney trans-
plant can vary between patients. To keep the same image 
orientation with respect to the inflowing blood direction 
as used for native kidneys, the plane of the image acquisi-
tion should be oriented along the long axis of the kidney 
body. For FAIR ASL-based methods, it can be challeng-
ing to plan the positioning of the imaging and selective 
inversion planes along the long axis of the transplanted 
kidney, while at the same time avoiding the abdominal aor-
tic and iliac feeding arteries (see Fig. 8). Although FAIR 
ASL has been shown to be feasible and repeatable using 
an oblique sagittal orientation [76], PCASL and related 
methods that provide greater flexibility in positioning of 
the imaging and labelling planes may be preferable in the 
transplant setting. It is recommended to plan the PCASL 
labelling plane perpendicular to the abdominal aorta, just 
above the bifurcation into the iliac arteries (see Fig. 7). 
This is a clear landmark to use for planning, independent 
of a left- or right-sided transplant location, and ensures 
that the labelling plane does not coincide with the kidney 
transplant. It is worth noting that even though blood flow 
velocity is lower at this location [95], the recommended 
PCASL parameters should still enable efficient labelling.
Furthermore, readout recommendations for transplanted 
kidneys are the same as those for native kidneys.
Limitations
Despite efforts in the inclusion of as broad representation 
of renal ASL experts as possible, the panel that partici-
pated in this consensus formation process was of limited 
size (n = 23), which can be considered a shortcoming 
of this work. However, it included scientists and clini-
cians from groups that have had a major impact on the 
Fig. 7  Renal transplantation and vascular anatomy. Adapted from 
https ://commo ns.wikim edia.org/wiki/File:Kidne y_Trans plant .png. 
[Accessed 21 Oct 2019] under the Creative Commons Attribution-
Share Alike 4.0 International license
Fig. 8  Positioning of the FAIR selective inversion slab (in purple), 
imaging slice (in orange) and QUIPSSII type saturation slab (in 
green) is shown on anatomical localizers in the coronal, axial and 
sagittal orientations for a transplant kidney. Planning of the FAIR 
ASL scan for transplant kidneys can be challenging due to the neces-
sity of avoiding the inclusion of the aortic and iliac feeding arteries 
within the selective inversion slab
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development of renal ASL and its application. The pro-
portion of technically oriented panel members was higher 
than that of clinically oriented ones. Although the involve-
ment of more clinicians would have been desirable, this 
is justified given the current state of development of renal 
ASL. Although most major technical hurdles have been 
resolved, the use of ASL in the kidney is still confined to 
a limited number of dedicated research groups.
During the process of consensus formation, panel mem-
bers were instructed to score the statements considering 
data available in the renal ASL literature, whenever pos-
sible. Another limitation of this work is that experimental 
data were lacking to provide a definitive answer for certain 
issues. When no published data were available to support a 
specific statement or the existing evidence was not strong, 
members were asked to provide an answer based on their 
expert opinion. The consensus protocol proposed here can 
thus be considered a starting point that will likely be modi-
fied in the future as more data become available, since the 
literature in the field is rapidly expanding.
In spite of the growing interest in renal ASL, data on 
clinical applications are still scarce. Thus, the provided 
protocol is intended as a tool to promote the clinical 
translation of the technique to be used mostly in clini-
cal research studies, rather than for direct application in 
patient care.
Finally, the recommended protocol parameters have 
been selected to provide robust measurements of cortical 
renal perfusion, since acquired data on medullary perfu-
sion are not considered to be well validated with current 
measurement approaches.
Future directions
We expect future research to address some of the limita-
tions in these recommendations. Lack of direct compari-
sons of ASL labelling schemes in the kidneys precluded 
us from recommending a single labelling strategy. More 
studies on patient populations are required to clarify the 
utility of ASL for characterizing renal disease and affect-
ing patient management. We recognize that no single 
standardized protocol will be ideal for all clinical appli-
cations but at the very least a wider application of renal 
ASL will inform where the present recommendations 
are suboptimal. An example might be cases where renal 
pathology which causes significant haemodynamic and/
or microstructural changes may require more complex 
acquisitions (e.g. multiple time points for mapping arte-
rial transit times) and/or analyses (e.g. two-compartment 
modelling to account for differences between blood and 
tissue T1).
In parallel to the uptake of renal ASL for clinical studies, 
we expect future technical developments to continue improv-
ing renal ASL measurements. Perfusion measurements in the 
medulla have only been reported in a small subset of renal 
ASL studies (e.g. [56, 63, 71]), probably due to technical 
challenges, as outlined previously in the quantification sec-
tion, which lead to a lower reproducibility when compared 
to the cortex. However, recent reports suggest an increasing 
feasibility of medullary perfusion mapping [15, 16, 96] and 
clinical need is likely to continue driving developments in 
this application as alterations in medullary perfusion may 
be implicated in certain pathologies characterized by renal 
tubular injury (e.g. AKI). This, and other applications, may 
be further potentiated by improvements in data processing 
and analysis pipelines, which we expect in the future to 
more effectively address remaining common artefacts such 
as motion, image distortion and/or partial volume effects 
while also optimizing clinical workflows by enabling effi-
cient visualization and interpretation of perfusion-weighted 
data and quantitative perfusion maps through streamlined 
software. ASL is also anticipated to be an important compo-
nent of multiparametric MRI protocols where the synergistic 
combination with other non-invasive MRI biomarkers will 
likely deliver greater diagnostic value [60].
Conclusions/summary
In summary, this work provides a recommended protocol for 
renal ASL chosen by consensus by a panel of experts in the 
field. It aims to provide a starting point to facilitate the use 
of renal ASL to those lacking experience and to promote the 
standardization of the acquisition and analysis steps in order 
to enable data comparison across centers and the establish-
ment of multi-center clinical studies.
As a default protocol we have recommended PCASL or 
FAIR labelling with a single-slice SE-EPI readout, with 
background suppression, and a simple but robust quantifi-
cation model. This should provide renal cortical perfusion 
images of adequate quality and SNR for most applications. 
For conditions where extended kidney coverage is desirable, 
a multislice SE-EPI readout can be employed. 3D readouts 
are promising but the lack of experience in renal ASL pre-
cludes recommendation of their use as the default approach.
With these recommendations we do not intend in any 
way to slow innovation or development in the field. Moreo-
ver, based on the panel discussions, certain issues have been 
identified as research priorities, including areas where strong 
evidence would be desirable, as highlighted in the “Future 
directions” section.
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